Upon verification, healthcare professionals have access to Eli Lilly product information and professional resources. Get answers to medical questions and access to Lilly scientific resources.

Upon verification, healthcare professionals have access to Eli Lilly product information and professional resources. Get answers to medical questions and access to Lilly scientific resources.

Nov 7, 2022 · Here's how the platform works: The Tempo Smart Button is a reusable medical device that attaches to the top of a Tempo Pen ― Lilly 's prefilled, disposable insulin pens approved in 2019 and 2020. When paired via Bluetooth ® wireless technology, the Smart Button is intended to detect, store and transfer insulin dose-related data to the ...

For more than 145 years, we have worked tirelessly to develop and deliver trusted medicines and diagnostics that meet real needs. Our growing portfolio of medicines includes treatments in the areas of bone muscle joint, cancer, cardiovascular, diabetes, endocrine, immunology, neuroscience and obesity.

Learn the latest information on the availability of Lilly diabetes and obesity medicines. Learn how to protect yourself from counterfeit Mounjaro ® and Zepbound ® and unapproved tirzepatide products.

Jan 22, 2025 · After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management platform, underpinned by digital technologies.

5 days ago · Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance.

Jan 15, 2025 · Omvoh ® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. About Lilly Lilly is a medicine company turning science into healing to make life better for people around the world.

Zepbound ® and its delivery device base and LillyDirect ® are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. Zepbound is available by prescription only. Lilly Support Services ™ and boundfor ™ are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. All ...

INDIANAPOLIS, Jan. 23, 2024 /PRNewswire/ -- Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), today announced positive initial clinical results from the Phase 1/2 AK-OTOF-101 study, ... is assessing the safety, tolerability, and bioactivity of escalating doses of AK-OTOF delivered via the Akouos delivery device.